10 Results for "

Proteasome Inhibitor1

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Proteasome Inhibitor1" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-114170
CAS No.: 1140517-08-3
Purity:  ≥98.0%
Target:  

Proteasome

Research Areas:  

Inflammation/Immunology

ML604440 is a specific and cell-permeable Proteasome β1i (LMP2) subunit inhibitor. ML604440 can be used in experimental colitis, EAE and autoimmune disease research. ML604440 shows synergistic effects and advantageous when combined with LMP7 inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139606
CAS No.: 2630950-38-6
Target:  

p97

Research Areas:  

Cancer

VCP/p97 inhibitor-1 is a potent inhibitor of VCP/p97 (also called Cdc48, CDC-. 48, or Ter94) with an IC50 of 54.7 nM. VCP/p97 inhibitor-1 causes the dysregulation of protein homeostasis and disturbs the degradation of misfolded polypeptides by the ubiquitin-proteasome system (UPS) .
loading...
    loading...
Cat. No.: HY-P1258
CAS No.: 158442-41-2
Synonyms: Proteasome Inhibitor 1; Z-Ile-Glu(OtBu)-Ala-Leu-CHO
Target:  

Proteasome

Research Areas:  

Infection Cancer

PSI (Proteasome Inhibitor 1) is a potent proteasome inhibitor. PSI inhibits the proliferation of primary effusion lymphoma (PEL) cells. PSI has the potential for the research of Kaposi’s sarcoma-associated herpesvirus (KSHV) infection and KSHV-associated lymphomas .
loading...
    loading...
Cat. No.: HY-144452
CAS No.: 2755772-63-3
Purity:  99.59%
Target:  

Proteasome

Research Areas:  

Cancer

Immunoproteasome inhibitor 1 is a potent, reversible, time-independent immunoproteasome and proteasome inhibitor (Kis of 1.18, 0.27, 1.91 μM in β5c, β1i, β5i submits, respectively). Immunoproteasome inhibitor 1 can be used for the research of certain neoplastic diseases .
loading...
    loading...
Cat. No.: HY-P1258A
Synonyms: Proteasome Inhibitor 1 TFA; Z-Ile-Glu(OtBu)-Ala-Leu-CHO TFA
Target:  

Proteasome

Research Areas:  

Infection Cancer

PSI (TFA) is a potent proteasome inhibitor. PSI (TFA) inhibits the proliferation of primary effusion lymphoma (PEL) cells. PSI (TFA) can be used for the research of Kaposi’s sarcoma-associated herpesvirus (KSHV) infection and KSHV-associated lymphomas .
loading...
    loading...
Cat. No.: HY-158325
CAS No.: 2956722-48-6
Target:  

PROTACs FLT3 Apoptosis

Research Areas:  

Cancer

PROTAC FLT-3 degrader 4 is an orally active CRBN-based FLT3-PROTAC degrader that potently induces FLT3-ITD degradation through the ubiquitin-proteasome system. PROTAC FLT-3 degrader 4 shows highly selective to FLT3-ITD mutant acute myeloid leukemia (AML) cells. (Blue: CRBN ligand, Black: linker; Pink: FLT3 inhibitor) .
loading...
    loading...
Cat. No.: HY-157032
CAS No.: 1613134-34-1
Target:  

Proteasome

Research Areas:  

Others

Proteasome-IN-5 (compound 5) is a proteasome inhibitor .
loading...
    loading...
Cat. No.: HY-157035
CAS No.: 2322333-75-3
Target:  

Proteasome

Research Areas:  

Others

Proteasome β2c/i-IN-1 (compound 37) is a subunit-selective human proteasome β2c and β2i inhibitor .
loading...
    loading...
Cat. No.: HY-N11620
Sadopeptins A is a nature product that could be isolated from Streptomyces sp. Sadopeptins A is a potent proteasome inhibitor .
loading...
    loading...
Cat. No.: HY-N11621
Sadopeptins B is a nature product that could be isolated from Streptomyces sp. Sadopeptins B is a potent proteasome inhibitor .
loading...
    loading...